Literature DB >> 10671227

TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions.

L T Nguyen1, K McKall-Faienza, A Zakarian, D E Speiser, T W Mak, P S Ohashi.   

Abstract

Deletion of mature T cells maintains cellular homeostasis and is involved in the maintenance of self tolerance to some peripheral self antigens. Previous studies have presented conflicting evidence for a role of the tumor necrosis factor receptor (TNFR) family member CD95 (Fas) in peripheral T cell deletion using CD95-deficient mice. To evaluate cooperation between CD95 and another TNFR family molecule, TNFR1, we generated mice deficient for both CD95 and TNFR1. We showed that TNFR1 and CD95 do not contribute to the decline of antigen-specific cytotoxic T lymphocytes after virus infection. Using TNFR1 / CD95-deficient mice expressing the P14 TCR specific for a lymphocytic choriomeningitis virus-derived peptide (p33) we showed that deletion of p33-specific CD8(+) T cells following high dose p33 administration is also normal. However, in non-TCR-transgenic TNFR1 / CD95-deficient mice treated with the same p33 regimen, tolerance induction was defective. These data indicate that TNFR1 and CD95 are dispensable for deletion of antigen-specific T cells after viral infection. However, under certain conditions, both TNFR1 and CD95 appear to cooperate in CD8(+) T cell deletion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671227     DOI: 10.1002/1521-4141(200002)30:2<683::AID-IMMU683>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.

Authors:  Shenghua Zhou; Rong Ou; Lei Huang; Demetrius Moskophidis
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering.

Authors:  Elena Sandalova; Cheng-Hong Wei; Maria G Masucci; Victor Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

3.  Role of Bim in regulating CD8+ T-cell responses during chronic viral infection.

Authors:  Jason M Grayson; Ashley E Weant; Beth C Holbrook; David Hildeman
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Acquisition of antigen presentasome (APS), an MHC/costimulatory complex, is a checkpoint of memory T-cell homeostasis.

Authors:  Sven Mostböck; Marta Catalfamo; Yutaka Tagaya; Jeffrey Schlom; Helen Sabzevari
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

Review 5.  Intrinsic and extrinsic control of effector T cell survival and memory T cell development.

Authors:  Timothy W Hand; Susan M Kaech
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

6.  The Bcl-2 family pro-apoptotic molecule, BNIP3 regulates activation-induced cell death of effector cytotoxic T lymphocytes.

Authors:  J Wan; D Martinvalet; X Ji; C Lois; S M Kaech; U H Von Andrian; J Lieberman; R Ahmed; N Manjunath
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

7.  Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection.

Authors:  M Suresh; Anju Singh; Christopher Fischer
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 8.  Apoptosis and autophagy in the regulation of T lymphocyte function.

Authors:  Alexis Dunkle; You-Wen He
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

9.  Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Authors:  Judith J Ryon; William J Moss; Mwaka Monze; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

10.  Death pathways in T cell homeostasis and their role in autoimmune diabetes.

Authors:  Matthew A Gronski; Michael Weinem
Journal:  Rev Diabet Stud       Date:  2006-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.